Sung Hee Hong
Overview
Explore the profile of Sung Hee Hong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lim H, Lee J, Kwon Y, Moon H, Park J, Kim K, et al.
Gut Liver
. 2025 Feb;
PMID: 39949051
Background/aims: Clinical data on the efficacy and safety of the dual delayed-release formulation of 10-mg esomeprazole (HIP2101) are currently limited. Therefore, this study compared the efficacy and safety of HIP2101...
2.
Kim Y, Bae S, Jeon I, Kwon J, Hong S, Kim N, et al.
Clin Ther
. 2024 Sep;
46(11):870-876.
PMID: 39289057
Purpose: A fixed-dose combination (FDC) of proton pump inhibitors (PPIs) and antacid salts enables rapid acid suppression through the neutralizing effect of the antacid salt and the rapid absorption of...
3.
Choi Y, Hwang J, Kim J, Min H, Seong C, Hong S, et al.
Clin Ther
. 2024 Jul;
46(8):622-628.
PMID: 39033046
Purpose: Gastritis, one of the most common clinically diagnosed conditions, is defined as the infiltration of inflammatory cells into the gastric mucosa. Drugs for gastritis include histamine-2 receptor antagonists and...
4.
Park J, Chung H, Kim J, Kim N, Hong S, Kim K, et al.
Drugs R D
. 2024 May;
24(2):179-186.
PMID: 38775910
Background And Objective: This study aimed to assess and compare the pharmacokinetics, safety, and tolerability of a fixed-dose combination product (FDCP) comprising four different drugs (two antihypertensive drugs, amlodipine and...
5.
Hong S, Lee J, Chung G
J Adolesc
. 2024 May;
96(6):1388-1396.
PMID: 38752304
Introduction: Patterns of biethnic adolescents' perceived biethnic acceptance across families, peers, and school contexts were examined during the transition from elementary to middle school in South Korea. We also examined...
6.
Hong S, Kim K, Chung G, Han G
J Fam Psychol
. 2024 Jan;
38(3):476-483.
PMID: 38271069
When children reach a certain age of maturity, middle-aged parents often reflect on their parenting, harboring continuous worries about their adult children. These parenting experiences are also shared within couples...
7.
Lim H, Park J, Chung H, Lee S, Park J, Park J, et al.
BMC Gastroenterol
. 2023 Dec;
23(1):447.
PMID: 38110901
Background: Proton-pump inhibitors (PPIs) are the most effective drugs for treating acid-related disorders. However, once-daily dosing with conventional PPIs fail to fully control acid secretion over 24 h. This study...
8.
Kim H, Yang E, Ban M, Kim Y, Hong S, Jung J, et al.
Drug Des Devel Ther
. 2023 Apr;
17:1115-1124.
PMID: 37077412
Background: Esomeprazole, a proton pump inhibitor (PPI), is widely used to treat acid-related disorders, but it has short plasma half-life which can cause insufficient gastric acid suppression, such as nocturnal...
9.
Lee M, Yoon S, Kim H, Cho Y, Han S, Lee S, et al.
Drug Des Devel Ther
. 2023 Apr;
17:1107-1114.
PMID: 37077410
Purpose: The combined administration of bazedoxifene, a tissue-selective estrogen receptor modulator, and cholecalciferol can be a promising therapeutic option for postmenopausal osteoporosis patients. This study aimed to examine the pharmacokinetic...
10.
Hwang S, Hong S, Jung J, Chung J, Jang I, Lee S
Clin Pharmacol Drug Dev
. 2023 Mar;
12(8):839-844.
PMID: 36929154
A novel dual delayed-release formulation (DR) of esomeprazole was developed to prolong the effect of esomeprazole inhibiting gastric acid secretion. This study investigated the effect of food on the pharmacokinetics...